Back to User profile » Dr Xinlu Yuan
Papers published by Dr Xinlu Yuan:
The Renal Micro-Vasculopathy and Systemic Aldosterone-Renin Ratio (ARR) in Type 2 Diabetic Patients—A Retrospective Real-World Study
Wen S, Xu Z, Gong M, Wang C, Yuan Y, Li Y, Dong M, Wang C, Xu D, Yuan X, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4229-4245
Published Date: 14 November 2025
The Therapeutic Effect and Mechanism of Traditional Chinese Medicine in Type 2 Diabetes Mellitus and Its Complications
Wen S, Zhang H, Huang X, Wang C, Dong M, Wang C, Xu C, Yuan Y, Li Y, Zhou L, Yuan X
Diabetes, Metabolic Syndrome and Obesity 2025, 18:1599-1627
Published Date: 15 May 2025
The Effect of Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic on the Metabolic Tumor Markers: A Real-World Retrospective Study
Wen S, Xu D, Yuan Y, Xu Z, Li Y, Gong M, Yuan X, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2024, 17:4115-4133
Published Date: 1 November 2024
The Relationship Between Computerized Face and Tongue Image Segmentation and Metabolic Parameters in Patients with Type 2 Diabetes Based on Machine Learning
Wen S, Li Y, Xu C, Jin J, Xu Z, Yuan Y, Chen L, Ren Y, Gong M, Wang C, Dong M, Zhou Y, Yuan X, Li F, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2024, 17:4049-4068
Published Date: 29 October 2024
The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot
Li X, Wen S, Dong M, Yuan Y, Gong M, Wang C, Yuan X, Jin J, Zhou M, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3197-3211
Published Date: 17 October 2023
Therapeutic Approaches for Nonalcoholic Fatty Liver Disease: Established Targets and Drugs
Huang X, Chen H, Wen S, Dong M, Zhou L, Yuan X
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1809-1819
Published Date: 21 June 2023
The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance
Dong M, Chen H, Wen S, Yuan Y, Yang L, Li Y, Yuan X, Xu D, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:425-435
Published Date: 14 February 2023
An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is)
Wen S, Nguyen T, Gong M, Yuan X, Wang C, Jin J, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2021, 14:2955-2972
Published Date: 29 June 2021
Low TSH Levels Within Euthyroid Range Could Play a Negative Role on Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes
Liu C, Pan J, Wen S, Nguyen T, Xu D, Wang C, Yuan X, Wen Z, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2021, 14:2349-2355
Published Date: 24 May 2021
Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice
Nguyen T, Wen S, Gong M, Yuan X, Xu D, Wang C, Jin J, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2020, 13:2781-2799
Published Date: 5 August 2020